Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Dejnirattisai, W.; Huo, J.; Zhou, D.; Zahradni_k, J.; Supasa, P.; Liu, C.; Duyvesteyn, H. M. E.; Ginn, H.; Mentzer, A. J.; Tuekprakhon, A.; Nutalai, R.; Wang, B. -; Dijokaite, A.; Khan, S.; Avinoam, O.; Bahar, M.; Skelly, D.; Adele, S.; Johnson, S.; Amini, A.; Ritter, T.; Mason, C.; Dold, C.; Pan, D.; Assadi, S.; Bellass, A.; Omo-Dare, N.; Koeckerling, D.; Flaxman, A.; Jenkin, D.; Aley, P. K.; Voysey, M.; Clemens, S. A. C.; Naveca, F. G.; Nascimento, V.; Nascimento, F.; da Costa, C. F.; Resende, P. C.; Pauvolid-Correa, A.; Siqueira, M. M.; Baillie, V.; Serafin, N.; Ditse, Z.; Silva, K. D.; Mad
Show abstract
On the 24th November 2021 the sequence of a new SARS CoV-2 viral isolate spreading rapidly in Southern Africa was announced, containing far more mutations in Spike (S) than previously reported variants. Neutralization titres of Omicron by sera from vaccinees and convalescent subjects infected with early pandemic as well as Alpha, Beta, Gamma, Delta are substantially reduced or fail to neutralize. Titres against Omicron are boosted by third vaccine doses and are high in cases both vaccinated and infected by Delta. Mutations in Omicron knock out or substantially reduce neutralization by most of a large panel of potent monoclonal antibodies and antibodies under commercial development. Omicron S has structural changes from earlier viruses, combining mutations conferring tight binding to ACE2 to unleash evolution driven by immune escape, leading to a large number of mutations in the ACE2 binding site which rebalance receptor affinity to that of early pandemic viruses.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion H69/V70 97%
- Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain 96%
- Convergence of a common solution to broad ebolavirus neutralization by glycan cap directed human antibodies 96%
Similar papers in this journal
- Structure selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern 95%
- Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2 95%
- Human cytomegalovirus deploys molecular mimicry to recruit VPS4A to sites of virus assembly 94%
Similar papers in this journal
Similar papers in this journal
- Cryo-ET of HIV reveals Env positioning on Gag lattice and structural variation among Env trimers 95%
- The Omicron variant is highly resistant against antibody-mediated neutralization - implications for control of the COVID-19 pandemic 95%
- Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.